U.S. Pharma Is Quietly Expanding Ties to Indian Generic Manufacturers
This article was originally published in PharmAsia News
Executive Summary
U.S. pharmaceutical companies have been trekking to India for a while to carry out clinical trials. But the relationships with Indian drug manufacturers have been quietly growing and now encompass the entire industry, according to a leader in the Indian pharmaceutical industry
You may also be interested in...
Indian CROs Move Up R&D Value Chain From Outsourcing Services To Partnering With MNCs
NEW DELHI - India, along with China, is increasingly becoming a popular destination for pharmaceutical research and development outsourced from the West, and more multinational companies are partnering with Indian CROs to improve productivity, cut costs and bring more drugs to market faster
Indian CROs Move Up R&D Value Chain From Outsourcing Services To Partnering With MNCs
NEW DELHI - India, along with China, is increasingly becoming a popular destination for pharmaceutical research and development outsourced from the West, and more multinational companies are partnering with Indian CROs to improve productivity, cut costs and bring more drugs to market faster
PharmAsia News Spotlight On India: Smaller R&D Units To Dominate India - Study
MUMBAI - India, which has now found a respectable place for itself on the global drug R&D map, could increasingly see smaller dedicated R&D units power the escalating research momentum in the country